Patent: 5,496,801
✉ Email this page to a colleague
Summary for Patent: 5,496,801
Title: | Parathyroid hormone formulation |
Abstract: | Described herein are preparations containing parathyroid hormone that has been stablized with an excipient and buffering agent. Preferred preparations incorporate human PTH(1-84), mannitol as excipient and citrate as buffering agent, and are incorporated in vials as a freeze-dried powder for reconstitution to treat osteoporosis. |
Inventor(s): | Holthuis; Josephus J. M. (AJ Leiden, NL), Mekking; Albert (CR Woerden, NL), Voetman; Alwinus A. (DT Zwanenburg, NL) |
Assignee: | Allelix BioPharmaceuticals Inc. (Ontario, CA) |
Application Number: | 08/172,206 |
Patent Claims: | see list of patent claims |
Details for Patent 5,496,801
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2039-03-29 |
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,496,801
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9517207 | ⤷ Try a Trial |
Slovakia | 82896 | ⤷ Try a Trial |
Portugal | 735896 | ⤷ Try a Trial |
Poland | 315158 | ⤷ Try a Trial |
New Zealand | 277463 | ⤷ Try a Trial |
Norway | 962634 | ⤷ Try a Trial |
Norway | 324905 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |